Whole transcriptome–based skin virome profiling in typical epidermodysplasia verruciformis reveals α-, β-, and γ-HPV infections
Authors:
- Amir Hossein SaeidianASAmir Hossein Saeidian
- Leila YoussefianLYLeila Youssefian
- Mahtab NajiMNMahtab Naji
- Hamidreza MahmoudiHMHamidreza Mahmoudi
- Samantha M. BarnadaSBSamantha M. Barnada
- Karim NaghipoorKNKarim Naghipoor
- Amir HozhabrpourAHAmir Hozhabrpour
- Jason S. ParkJPJason S. Park
- Fatemeh VahidnezhadFVFatemeh Vahidnezhad
- Zahra SaffarianZSZahra Saffarian
Open Access
- 8 March 2023
- journal article
- research article
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 8 (5)
Abstract
HPVs are DNA viruses include approximately 450 types that are classified into 5 genera (α-, β-, γ-, μ-, and ν-HPV). The γ- and β-HPVs are present in low copy numbers in healthy individuals; however, in patients with an inborn error of immunity, certain species of β-HPVs can cause epidermodysplasia verruciformis (EV), manifesting as recalcitrant cutaneous warts and skin cancer. EV presents as either typical or atypical. Manifestations of typical EV are limited to the skin and are caused by abnormal keratinocyte-intrinsic immunity to β-HPVs due to pathogenic sequence variants in TMC6 , TMC8 , or CIB1 . We applied a transcriptome-based computational pipeline, VirPy, to RNA extracted from normal-appearing skin and wart samples of patients with typical EV to explore the viral and human genetic determinants. In 26 patients, 9 distinct biallelic mutations were detected in TMC6 , TMC8 , and CIB1 , 7 of which are previously unreported to our knowledge. Additionally, 20 different HPV species, including 3 α-HPVs, 16 β-HPVs, and 1 γ-HPV, were detected, 8 of which are reported here for the first time to our knowledge in patients with EV (β-HPV-37, -47, -80, -151, and -159; α-HPV-2 and -57; and γ-HPV-128). This study expands the TMC6 , TMC8 , and CIB1 sequence variant spectrum and implicates new HPV subtypes in the pathogenesis of typical EV.Keywords
Funding Information
- National Institutes of Health (R01AI143810,R01AR080754)
- LEO Fondet (LF-OC-22-000965)
This publication has 38 references indexed in Scilit:
- STAR: ultrafast universal RNA-seq alignerBioinformatics, 2012
- Integrative Genomics Viewer (IGV): high-performance genomics data visualization and explorationBriefings in Bioinformatics, 2012
- Lack of EVER2 Protein in Two Epidermodysplasia Verruciformis Patients with Skin Cancer Presenting Previously Unreported Homozygous Genetic Deletions in the EVER2 GeneJournal of Investigative Dermatology, 2012
- A program for annotating and predicting the effects of single nucleotide polymorphisms, SnpEffFly, 2012
- The Sequence Alignment/Map format and SAMtoolsBioinformatics, 2009
- Treatment of a patient with epidermodysplasia verruciformis carrying a novel EVER2 mutation with imiquimodJournal of the American Academy of Dermatology, 2007
- Genetics of epidermodysplasia verruciformis: Insights into host defense against papillomavirusesSeminars in Immunology, 2006
- Why epidermodysplasia verruciformis – a rare genetic disease – has raised such great interestInternational Journal of Dermatology, 2004
- Mutations in two adjacent novel genes are associated with epidermodysplasia verruciformisNature Genetics, 2002
- Ein Fall einer bisher nicht beschriebenen Hauterkrankung (Epidermodysplasia verruciformis)Archives of Dermatological Research, 1922